PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Percutaneous repair of valve leaks: A new treatment for patients at high risk of cardiac surgery

PCI repair can mitigate known risks that accompany increases in implanted valves

2013-11-01
(Press-News.org) Contact information: Steve Goodyear
sgoodyear@mhif.org
612-863-1658
Minneapolis Heart Institute Foundation
Percutaneous repair of valve leaks: A new treatment for patients at high risk of cardiac surgery PCI repair can mitigate known risks that accompany increases in implanted valves MINNEAPOLIS, MN—October 31, 2013—A Paravalvular regurgitation, or leakage, commonly affects valvular prostheses, particularly artificial valves placed percutaneously according to data presented at the 2013 Transcatheter Cardiovascular Therapeutics (TCT) conference. Building on existing data, research cardiologist Paul Sorajja MD, of the Minneapolis Heart Institute Foundation delivered a presentation on current percutaneous techniques that sheds light on the complexities of the treatment of paravalvular prosthetic regurgitation, or heart valve leakage. This research represents new advances for patients who have few or no surgical options

Significant paravalvular prosthetic regurgitation occurs in as many as 1 in 7 patients suffering from valvular heart disease. Traditional treatment has been open heart surgery. Percutaneous repair of paravalvular prosthetic regurgitation can now be performed with a high rate of procedural success and has become the preferred initial therapeutic option, particularly in patients at significant risk for more invasive surgery.

"Paravalvular prosthetic regurgitation, or heart valve leakage, recently has been associated with not only heart failure and anemia but also a greater risk of death after what is initially deemed to be a successful surgery," said Paul Sorajja, MD, research cardiologist at the Minneapolis Heart Institute Foundation and Director, Center for Valve and Structural Heart Disease, Minneapolis Heart Institute at Abbott Northwestern Hospital. "New data has shown that leakage is actually more common in percutaneous valves than surgically implanted prostheses. How we manage paravalvular leaks therefore becomes increasingly important as more and more patients are receiving valves percutaneously. These patients are typically at high-risk of cardiac surgery so being able to treat these leaks with new percutaneous techniques is more important than ever before."

Two-year data from a current clinical trial called PARTNER II cites follow-up analysis of patients at high-risk of cardiac surgery who underwent transcatheter aortic valve replacement, or TAVR, and is one study referenced by Dr. Sorajja. In that study, the presence of prosthetic paravalvular regurgitation, even when mild, was associated with 1.5- to 2-fold increase in the risk of death.

"We do not yet know if percutaneous repair can address this increased risk, but it is incredibly important to be able to successfully treat these defects percutaneously, as these patients have few, if any, surgical options," said Dr. Sorajja.

The data suggests that while percutaneous repair of paravalvular prosthetic regurgitation can lead to durable symptom relief in selected patients, mortality remains significant and long-term clinical efficacy is highly dependent on residual regurgitation. Patient selection, comprehensive imaging, and operator experience are keys to the success of percutaneous repair of paravalvular leak.

"There is a new significant learning curve, which can be addressed with a detailed patient evaluation, close collaboration with colleagues who have expertise in imaging, and operator experience in new techniques," said Dr. Sorajja. These techniques currently are available only at tertiary referral centers, but should become more available as more interventionalists adopt them and bring them to the rapidly increasing number of patients who would benefit from their use."

### About the Minneapolis Heart Institute Foundation The Minneapolis Heart Institute Foundation is dedicated to improving people's lives through the highest quality cardiovascular research and education. Scientific Innovation and Research – Publishing more than 120 peer-reviewed studies each year, MHIF is a recognized research leader in the broadest range of cardiovascular medicine. Each year, cardiologists and hospitals around the world adopt MHIF protocols to save lives and improve patient care. Education and Outreach – Research shows that modifying specific health behaviors can significantly reduce the risk of developing heart disease. Through community programs, screenings and presentations, MHIF educates people of all walks of life about heart health. The goal of the Foundation's community outreach is to increase personal awareness of risk factors and provide the tools necessary to help people pursue heart- healthy lifestyles.

About the Minneapolis Heart Institute® The Minneapolis Heart Institute® is recognized internationally as one of the world's leading providers of heart and vascular care. This state-of-the-art facility combines the finest in personalized patient care with sophisticated technology in a unique, family-oriented environment. The Institute's programs, a number of which are conducted in conjunction with Abbott Northwestern Hospital, address the full range of heart and vascular health needs: prevention, diagnosis, treatment and rehabilitation.


ELSE PRESS RELEASES FROM THIS DATE:

Results of the TATORT-NSTEMI trial presented at TCT 2013

2013-11-01
Results of the TATORT-NSTEMI trial presented at TCT 2013 Removing blood clots during PCI does not improve outcomes compared to standard angioplasty in patients with non-ST-elevation myocardial infarction SAN FRANCISCO, CA – OCTOBER 31, 2013 – According to a new study, ...

Results of the REPRISE II trial reported at TCT 2013

2013-11-01
Results of the REPRISE II trial reported at TCT 2013 Second generation transcatheter aortic valve shown to successfully address complications of TAVR SAN FRANCISCO, CA – THURSDAY OCTOBER 31, 2013 – In a clinical trial, a second-generation transcatheter aortic valve demonstrated ...

Experimental drug shows encouraging results in treating most common form of lung cancer

2013-11-01
Experimental drug shows encouraging results in treating most common form of lung cancer An experimental cancer drug that has shown promise in the treatment of melanoma has also shown early potential as an effective treatment for patients with non-small ...

Oligomeric proanthocyanidin suppresses the death of retinal ganglion cells

2013-11-01
Oligomeric proanthocyanidin suppresses the death of retinal ganglion cells The death of retinal ganglion cells is a hallmark of many optic neurodegenerative diseases such as glaucoma and retinopathy. Oxidative stress is one of the major reasons to cause the ...

Can Aβ worsen cognitive impairment following cerebral ischemia-reperfusion injury?

2013-11-01
Can Aβ worsen cognitive impairment following cerebral ischemia-reperfusion injury? Amyloid β-peptide, a major component of senile plaques in Alzheimer's disease, has been impli-cated in neuronal cell death and cognitive impairment. Recently, studies ...

Low-frequency rTMS prevents chronic epileptic seizure

2013-11-01
Low-frequency rTMS prevents chronic epileptic seizure Although increasing evidence indicates that low-frequency repetitive transcranial magnetic stimulation (rTMS), an emerging technology for neural regulation, has antiepileptic effects, the mechanism remains unclear. ...

Exposure to cortisol-like medications before birth may contribute to emotional problems and brain changes

2013-11-01
Exposure to cortisol-like medications before birth may contribute to emotional problems and brain changes Reports new study in Biological Psychiatry Philadelphia, PA, October 31, 2013 – Neonatologists seem to perform miracles in the fight to support the survival of ...

JCI early table of contents for Nov. 1, 2013

2013-11-01
JCI early table of contents for Nov. 1, 2013 Liver tropism is key for B cell deletion immunotherapy Antibodies against the B cell surface protein CD20 have been used successfully to treat B cell-mediated autoimmune diseases and lymphomas. Antibody binding ...

Liver tropism is key for B cell deletion immunotherapy

2013-11-01
Liver tropism is key for B cell deletion immunotherapy Antibodies against the B cell surface protein CD20 have been used successfully to treat B cell-mediated autoimmune diseases and lymphomas. Antibody binding receptors, called Fc receptors, on other ...

Dysfunctional chemokine receptor promotes candidiasis

2013-11-01
Dysfunctional chemokine receptor promotes candidiasis Candida albicans is one of the leading causes of hospital-acquired infections in immune compromised patients. The risk of both developing candidiasis and the clinical outcome of infection is variable ...

LAST 30 PRESS RELEASES:

Dolphins use a 'fat taste' system to get their mother’s milk

Clarifying the mechanism of coupled plasma fluctuations using simulations

Here’s what’s causing the Great Salt Lake to shrink, according to PSU study

Can DNA-nanoparticle motors get up to speed with motor proteins?

Childhood poverty and/or parental mental illness may double teens’ risk of violence and police contact

Fizzy water might aid weight loss by boosting glucose uptake and metabolism

Muscular strength and good physical fitness linked to lower risk of death in people with cancer

Recommendations for studying the impact of AI on young people's mental health  proposed by Oxford researchers

Trump clusters: How an English lit graduate used AI to make sense of Twitter bios

Empty headed? Largest study of its kind proves ‘bird brain’ is a misnomer

Wild baboons not capable of visual self-awareness when viewing their own reflection

$14 million supports work to diversify human genome research

New study uncovers key mechanism behind learning and memory

Seeing the unseen: New method reveals ’hyperaccessible’ window in freshly replicated DNA

Extreme climate pushed thousands of lakes in West Greenland ‘across a tipping point,’ study finds

Illuminating an asymmetric gap in a topological antiferromagnet

Global public health collaboration benefits Americans, SHEA urges continued support of the World Health Organization

Astronomers thought they understood fast radio bursts. A recent one calls that into question.

AAAS announces addition of Journal of EMDR Practice and Research to Science Partner Journal program

Study of deadly dog cancer reveals new clues for improved treatment

Skin-penetrating nematodes have a love-hate relationship with carbon dioxide

Fewer than 1% of U.S. clinical drug trials enroll pregnant participants, study finds

A global majority trusts scientists, wants them to have greater role in policymaking, study finds

Transforming China’s food system: Healthy diets lead the way

Time to boost cancer vaccine work, declare UK researchers

Colorado State receives $326M from DOE/EPA to improve oil and gas operations and reduce methane emissions

Research assesses how infertility treatments can affect family and work relationships

New findings shed light on cell health: Key insights into the recycling process inside cells

Human papillomavirus infection kinetics revealed in new longitudinal study

Antibiotics modulate E. coli’s resistance to phages

[Press-News.org] Percutaneous repair of valve leaks: A new treatment for patients at high risk of cardiac surgery
PCI repair can mitigate known risks that accompany increases in implanted valves